Natera

immune system fighting cancer cells
MedTech

Natera teams with Angiex on cancer drug trial monitoring

Natera inked a deal with biotech Angiex to assess its Signatera blood test, which detects traces of cancer DNA in patients treated for the disease.
Joseph Keenan Aug 31, 2026 5:56pm
Morrissey
Favicon Fierce Pharma

Exelixis aims to be a top 5 solid tumor drugmaker in the US: CEO

Jan 16, 2026 1:00pm
Laboratory

Natera buys Foresight Diagnostics in $450M cancer testing deal

Dec 5, 2025 11:57am
Tecentriq
Favicon Fierce Pharma

Roche touts Tecentriq biomarker win in bladder cancer

Aug 18, 2025 4:17pm
blood test tube

Guardant awarded $292M in false advertising suit against Natera

Nov 26, 2024 10:45am
acquisition merger MA chess game

Natera offers Invitae $52.5M for prenatal screening tests

Jan 22, 2024 10:27am